Safety of Graded-Dose of Histidine in Humans
NCT04142294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-02-07
Summary
Histidine is an essential amino acid with health benefits that include anti-inflammatory, anti-oxidant, glucoregulatory, and weight management. The current expert opinion for histidine intake is 8 and 12 mg/(kg body weight per day), an estimate that was extrapolated from the infant requirement for histidine. Further, the clinical safety of histidine supplementation above the average dietary intake has not been determined.The overarching objectives are to 1) measure the safety of histidine supplementation and 2) measure the potential benefits of histidine at doses above the average intake and current recommendation in a healthy adult population.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Histidine
ingestion of encapsulated high quality histidine for four continuous weeks followed by a washout period of 3 weeks
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-21
- Primary Completion
- 2019-08-31
- Completion
- 2019-08-31
Countries
- United States
Study Locations
More Related Trials
-
Vitamin B6 Dependence of One-Carbon Metabolism
NCT00877812 ·Status: COMPLETED ·Phase: NA
-
Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women
NCT04125940 ·Status: COMPLETED ·Phase: NA
-
Energetics and Function in Older Humans
NCT02348762 ·Status: COMPLETED ·Phase: PHASE1
-
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
NCT01111734 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Analysis in Human Sulfur Amino Acid Deficiency
NCT00253760 ·Status: COMPLETED ·Phase: NA
-
Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
NCT04005053 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Methionine and Cysteine Restriction in Healthy Adults
NCT02192437 ·Status: COMPLETED ·Phase: NA
-
Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
NCT00858273 ·Status: COMPLETED ·Phase: NA
-
Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities
NCT02321579 ·Status: UNKNOWN ·Phase: NA
-
Glutathione and Its Precursors in HIV-Infected Patients
NCT00910442 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Glutathione Supplementation on the Levels of Blood Glutathione
NCT01044277 ·Status: COMPLETED ·Phase: NA
-
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
NCT05371288 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Dynamic Aspects of Amino Acid Metabolism
NCT00005767 ·Status: UNKNOWN
-
The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia
NCT00780520 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Chemical Interactions in Toxicity
NCT00253773 ·Status: COMPLETED ·Phase: NA
-
Glutathione and Function in HIV Patients
NCT02348775 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)
NCT03063476 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis
NCT00227058 ·Status: COMPLETED ·Phase: NA
-
Prevention of Acute Radiation Enteritis With Glutamine
NCT00828399 ·Status: COMPLETED ·Phase: PHASE4
-
L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde
NCT02524262 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Effects of Sulfur Amino Acids
NCT00228618 ·Status: COMPLETED
-
Effects of L-lysine on Adrenal Secretion
NCT01220388 ·Status: COMPLETED ·Phase: NA
-
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
NCT02583672 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Liposomal Glutathione Supplementation in Healthy Subjects
NCT02278822 ·Status: COMPLETED ·Phase: NA
-
The Effect of Acute Lysine Administration on α-aminoadipic Acid
NCT02756117 ·Status: COMPLETED ·Phase: PHASE1